These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19587366)

  • 1. Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors.
    Elliott J; Tesfaye S; Chaturvedi N; Gandhi RA; Stevens LK; Emery C; Fuller JH;
    Diabetes Care; 2009 Oct; 32(10):1896-900. PubMed ID: 19587366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study.
    Martin CL; Waberski BH; Pop-Busui R; Cleary PA; Catton S; Albers JW; Feldman EL; Herman WH;
    Diabetes Care; 2010 Dec; 33(12):2635-41. PubMed ID: 20833868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does peripheral neuropathy invariably accompany nephropathy in type 1 diabetes mellitus?
    Shaw JE; Gokal R; Hollis S; Boulton AJ
    Diabetes Res Clin Pract; 1998 Jan; 39(1):55-61. PubMed ID: 9597375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of biothesiometry to detect neuropathy in children and adolescents with IDDM.
    Davis EA; Jones TW; Walsh P; Byrne GC
    Diabetes Care; 1997 Sep; 20(9):1448-53. PubMed ID: 9283795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated vibration perception threshold in young patients with type 1 diabetes in comparison to non-diabetic children and adolescents.
    Olsen BS; Nir M; Kjaer I; Vølund A; Mortensen HB
    Diabet Med; 1994 Nov; 11(9):888-92. PubMed ID: 7705028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds.
    Coppini DV; Wellmer A; Weng C; Young PJ; Anand P; Sönksen PH
    J Clin Neurosci; 2001 Nov; 8(6):520-4. PubMed ID: 11683597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration.
    Abbott CA; Vileikyte L; Williamson S; Carrington AL; Boulton AJ
    Diabetes Care; 1998 Jul; 21(7):1071-5. PubMed ID: 9653597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular risk factors and diabetic neuropathy.
    Tesfaye S; Chaturvedi N; Eaton SE; Ward JD; Manes C; Ionescu-Tirgoviste C; Witte DR; Fuller JH;
    N Engl J Med; 2005 Jan; 352(4):341-50. PubMed ID: 15673800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study.
    Coppini DV; Young PJ; Weng C; Macleod AF; Sönksen PH
    Diabet Med; 1998 Sep; 15(9):765-71. PubMed ID: 9737806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes.
    Rajaobelina K; Farges B; Nov S; Maury E; Cephise-Velayoudom FL; Gin H; Helmer C; Rigalleau V
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27235334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study.
    Young MJ; Breddy JL; Veves A; Boulton AJ
    Diabetes Care; 1994 Jun; 17(6):557-60. PubMed ID: 8082524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
    Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
    J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong association between vibration perception thresholds at low frequencies (4 and 8 Hz), neuropathic symptoms and diabetic foot ulcers.
    Lindholm E; Löndahl M; Fagher K; Apelqvist J; Dahlin LB
    PLoS One; 2019; 14(2):e0212921. PubMed ID: 30817797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative vibration perception threshold in assessing diabetic polyneuropathy: Should the cut-off value be adjusted for Chinese individuals with type 2 diabetes?
    Liu M; Gao Y; Chen DW; Lin S; Wang C; Chen LH; Ran XW
    J Diabetes Investig; 2021 Sep; 12(9):1663-1670. PubMed ID: 33512757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of vibration perception threshold in type 2 diabetic patients with proliferative retinopathy.
    Magri CJ; Calleja N; Buhagiar G; Fava S; Vassallo J
    Postgrad Med J; 2011 Oct; 87(1032):658-63. PubMed ID: 21954032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood.
    Olsen BS; Sjølie A; Hougaard P; Johannesen J; Borch-Johnsen K; Marinelli K; Thorsteinsson B; Pramming S; Mortensen HB
    J Diabetes Complications; 2000; 14(6):295-300. PubMed ID: 11120452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic patients.
    Ziegler D; Buchholz S; Sohr C; Nourooz-Zadeh J; Roden M
    Acta Diabetol; 2015 Feb; 52(1):65-72. PubMed ID: 24898524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between serum uric acid and large-nerve fiber dysfunction in type 2 diabetes: a cross-sectional study.
    Jiang TN; Li YF; Huo LL; Zhang Q; Wang LY; Zhao CL; Liu LG
    Chin Med J (Engl); 2019 May; 132(9):1015-1022. PubMed ID: 30925549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foot pressure measurements in diabetic and nondiabetic amputees.
    Veves A; Van Ross ER; Boulton AJ
    Diabetes Care; 1992 Jul; 15(7):905-7. PubMed ID: 1516512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.